Alison Bauerlein News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Alison bauerlein. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Alison Bauerlein Today - Breaking & Trending Today

Sight Sciences, Inc. (NASDAQ:SGHT) CFO Sells $70,817.72 in Stock

Sight Sciences, Inc. (NASDAQ:SGHT – Get Free Report) CFO Alison Bauerlein sold 13,066 shares of the firm’s stock in a transaction dated Friday, May 17th. The stock was sold at an average price of $5.42, for a total value of $70,817.72. Following the transaction, the chief financial officer now owns 413,182 shares of the company’s […] ....

United States , Alison Bauerlein , Piper Sandler , Needham Company , Sight Sciences Inc , Securities Exchange Commission , Swiss National Bank , Tower Research Capital , News Ratings For Sight Sciences Daily , Quarter For Sight Sciences , Sight Sciences Stock Down , Sight Sciences , First Eagle Investment Management , Jackson Square Partners , Get Free Report , Exchange Commission , Sciences Stock Down , Eagle Investment Management , National Bank , Square Partners , Research Capital , Surgical Glaucoma , Sight Sciences Daily ,

Sight Sciences, Inc. (NASDAQ:SGHT) Receives $4.70 Average Price Target from Analysts

Sight Sciences, Inc. (NASDAQ:SGHT) Receives $4.70 Average Price Target from Analysts
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United States , Paul Badawi , Alison Bauerlein , Piper Sandler , Analyst Recommendations For Sight Sciences , Insider Activity At Sight Sciences , Tower Research Capital , News Ratings For Sight Sciences Daily , Hermes Inc , First Eagle Investment Management , Needham Company , Sight Sciences Inc , Sight Sciences Stock Performance , Sight Sciences , Sight Sciences Company Profile , Swiss National Bank , Get Free Report , Eagle Investment Management , National Bank , Research Capital , Get Free , Surgical Glaucoma , Sight Sciences Daily ,

Sight Sciences, Inc. (NASDAQ:SGHT) Receives $4.70 Consensus Target Price from Brokerages

Sight Sciences, Inc. (NASDAQ:SGHT) Receives $4.70 Consensus Target Price from Brokerages
etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.

Alison Bauerlein , Piper Sandler , Paul Badawi , Needham Company , Securities Exchange Commission , News Ratings For Sight Sciences Daily , Sight Sciences Inc , Sight Sciences Stock Performance , Tower Research Capital , Jackson Square Partners , Analyst Recommendations For Sight Sciences , Sight Sciences , Mirae Asset Global Investments Co , Institutional Trading Of Sight Sciences , Get Free Report , Exchange Commission , Asset Global Investments , Research Capital , Square Partners , Get Free , Surgical Glaucoma , Sight Sciences Daily ,

Sight Sciences, Inc. (NASDAQ:SGHT) Q1 2024 Earnings Call Transcript

Operator: Good day, and thank you for standing by. Welcome to the Sight Sciences First Quarter 2024 Earnings Results Conference Call. At this time, all participants are in a listen-only mode. ....

United States , Paul Badawi , Tearcare Smartlids , David Saxon , Hydrus Microstent , William Blair , James Beers , Ali Bauerlein , Alison Bauerlein , American Academy Of Ophthalmology , District Court , Needham Company , Sight Sciences Co , Biggest Natural Gas Companies , Biggest Chemical Companies , Sight Sciences First Quarter , Sight Sciences , Outcomes Research , Exchange Commission , Sight Sciences Inc , International Society For Pharmacoeconomics , Call Transcript May , Results Conference , Trip Taylor , Investor Relations , Sight Sciences Co Founder ,

Sight Sciences' (SGHT) Neutral Rating Reiterated at Piper Sandler

Piper Sandler restated their neutral rating on shares of Sight Sciences (NASDAQ:SGHT – Free Report) in a research report released on Friday, Benzinga reports. The brokerage currently has a $6.00 target price on the stock, up from their previous target price of $5.00. Separately, Needham & Company LLC reaffirmed a hold rating on shares of […] ....

Alison Bauerlein , Piper Sandler , Paul Badawi , Needham Company , Sight Sciences , Analyst Recommendations For Sight Sciences , Sight Sciences Company Profile , Mirae Asset Global Investments Co , Sight Sciences Inc , News Ratings For Sight Sciences Daily , Jackson Square Partners , Sight Sciences Price Performance , Securities Exchange Commission , Tower Research Capital , Free Report , Get Free Report , Exchange Commission , Asset Global Investments , Research Capital , Square Partners , Surgical Glaucoma , Sight Sciences Daily , Nasdaq Sght , Reiterated Rating ,